Orencia 125 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F9HR9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,698
Award facts
- Contract value 100% obligated
- $11,698.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,698.43 to AmerisourceBergen Drug Corp for the supply of Orencia 125 mg/mL syringes. This non-set-aside, competitively awarded contract was finalized on December 29, 2025, with an ultimate completion date of December 30, 2025, and represents a firm fixed price delivery order for pharmaceutical supplies. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract vehicle—the DLA Troop Support Medical SPE2DX contract valued at $999,999,999.00 and extending through December 2026—which serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds this prime IDC as part of the Defense Logistics Agency's Medical Supply Chain operations. The parent contract supports the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems by supplying a broad range of pharmaceutical products, medical devices, vaccines, and specialized medical supplies across multiple therapeutic domains. The delivery order for Orencia, a biologic medication used in the treatment of rheumatoid arthritis, reflects the company's role in supplying critical specialty medications to support military healthcare requirements worldwide.
Quick answers
Who was awarded contract SPE2DR26F9HR9?
SPE2DR26F9HR9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26F9HR9 worth?
The government has obligated $11,698 on SPE2DR26F9HR9.
Is contract SPE2DR26F9HR9 an order under another contract?
Yes. SPE2DR26F9HR9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9HR9 competed?
The extent of competition for SPE2DR26F9HR9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award